Cytomegalovirus and simian immunodeficiency virus coinfection: longitudinal study of antibody responses and disease progression

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1;15(1):5-15. doi: 10.1097/00042560-199705010-00002.

Abstract

Antibody titers to rhesus cytomegalovirus (RhCMV) were prospectively analyzed over a period of 68 weeks in a longitudinal serosurvey of 17 RhCMV-seropositive rhesus macaques (Macaca mulatta) experimentally coinfected with simian immunodeficiency virus (SIV). These were compared with anti-RhCMV titers in 18 animals that were also naturally infected with RhCMV but not infected with SIV. Fluctuations in anti-RhCMV antibody titers were observed within 5 weeks of SIV inoculation, and two distinct patterns of RhCMV antibody response were observed in SIV-infected animals. Animals showing a progressive decline in anti-RhCMV immunoglobulin G (IgG) exhibited the most rapid disease progression, coincident with low anti-SIV and anti-tetanus toxoid IgG responses, high levels of p27 antigen in the plasma, and short survival. Animals exhibiting a more stable CMV-specific response after SIV inoculation had the least rapid disease course. Anti-RhCMV antibody titers in SIV-uninfected animals remained relatively stable during the period of study. Evidence that preinoculation immunologic measures predicted postinoculation outcome was equivocal.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Viral / blood*
  • CD4 Lymphocyte Count
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / immunology*
  • Cytomegalovirus Infections / pathology
  • Enzyme-Linked Immunosorbent Assay
  • Immunoglobulin G / blood
  • Macaca mulatta
  • Male
  • Simian Acquired Immunodeficiency Syndrome / complications
  • Simian Acquired Immunodeficiency Syndrome / immunology*
  • Simian Acquired Immunodeficiency Syndrome / pathology
  • Tetanus Toxoid / immunology

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Tetanus Toxoid